The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11067 malaria professionals are enjoying the free benefits of MalariaWorld today

policy

Malaria Test, Treat and Track policy implementation in Angola: a retrospective study to assess the progress achieved after 4 years of programme implementation

July 21, 2020 - 15:34 -- Open Access
Author(s): 
Sergio C. Lopes, Rukaaka Mugizi, João Esteves Pires, Fernando David, José Martins, Pedro Rafael Dimbu, Filomeno Fortes, Joana Rosário and Richard Allan
Reference: 
Malaria Journal 2020 19:262, 20 July 2020

Malaria is one of the main causes of death in Angola, particularly among children under 5 years of age. An essential means to improve the situation is with strong malaria case management; this includes diagnosing suspected patients with a confirmatory test, either with a rapid diagnostic test (RDT) or microscopy, prompt and correct treatment with artemisinin-based combination therapy (ACT), and proper case registration (track). In 2011, the United States President’s Malaria Initiative (PMI) launched a country-wide programme to improve malaria case management through the provision of regular training and supervision at different levels of health care provision. An evaluation of malaria testing, treatment and registration practices in eight provinces, and at health facilities of various capacities, across Angola was conducted to assess progress of the national programme implementation.

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of the September 2013 meeting

January 24, 2014 - 17:07 -- MESA Alliance
Tags: 

The Malaria Policy Advisory Committee to the World Health Organization held its fourth meeting in Geneva, Switzerland from 11 to 13 September, 2013. This article provides a summary of the discussions, conclusions and recommendations from that meeting. MESA is partnering with Global Malaria Programme to disseminate the report.

GM mosquitoes: A perspective from Oxitec

March 22, 2012 - 15:18 -- Bart G.J. Knols

The editorial below was written by Camilla Beech, Regulatory Affairs Manager,  Oxitec Ltd, UK, partially as a response to a recent editorial by Guy Reeves, on regulatory aspects of GM mosquitoes.

 

Having spent over 10 years developing novel genetic approaches to control insect pests, we’re acutely aware of the importance of proceeding with caution, of doing so in a transparent and open manner, and of engaging in the most effective way possible with the diverse communities who have an interest in the development and use of these new technologies.

Subscribe to RSS - policy